Cyclooxygenase inhibition converts the effect of nitric oxide synthase inhibition from infarct size reduction to expansion in isolated rabbit hearts

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 6, 1999, Pages 1315-1324

  Aitchison, Keri A ^a   Coker, Susan J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

6 Keto prostaglandin F(1 ); Cyclic GMP; Cyclooxygenase; Indomethacin; Infarct size; Ischaemia reperfusion; N(G) nitro L arginine; Nitric oxide; Nitric oxide synthase; Prostacyclin; Rabbit

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARGININE; CYCLIC GMP; INDOMETACIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; TETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION SIZE; ISCHEMIA; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RABBIT; REPERFUSION; STAINING; STATISTICAL ANALYSIS;

EID: 0033153441     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.0964     Document Type: Article

References (39)

1. Aitchison KA, Coker SJ, 1996. Effects of SIN-1 and iloprost, alone and in combination, on myocardial infarct size in anaesthetized rabbits (abstract). Br J Pharmacol 117: 54P.
2. Barker JE, Bakhle YS, Anderson J, TReasure T, Piper PJ, 1996. Reciprocal inhibition of nitric oxide and prostacyclin synthesis in human saphenous vein. Br J Pharmacol 118: 643-648.
3. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA, 1990. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624.
4. Berti F, Rossini G, Magni F, Curuso D, Omni C, Puglisi L, Galli G, 1988. Nonsteroidal antiinflammatory drugs aggravate acute myocardial ischemia in the perfused rabbit heart: A role for prostacyclin. J Cardiovasc Pharmacol 12: 438-444.
5. Berti G, Rossini D, Della Bella LM, Buschi A, Trento F, Berti M, Tondo C, 1993. Nitric oxide and prostacyclin influence coronary vasomotor tone in perfused rabbit heart and modulate endothelin-1 activity. J Cardiovasc Pharmacol 22: 321-326.
6. Bhagyalakshmi A, Frangos JA, 1989. Mechanism of shear stress-induced prostacyclin production in endothelial cells. Biochem Biophys Res Commun 158: 31-37.
7. Chambers DE, Yellon DM, Hearse DJ, Downey JM, 1983. Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: Reduction or delay? Am J Cardiol 51: 844-890.
8. Chiariello M, Golino P, Cappelli-Bigazzi M, Ambrosio G, Tritto I, Salvatore M, 1988. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion. Am Heart J 115: 499-504.
9. Coker SJ, Parratt JR, Ledingham IMcA, Zeitlin IJ, 1981. Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias. Nature 291: 323-324.
10. De Nucci G, Gryglewski RJ, Warner TD, Vane JR, 1988. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 85: 2334-2338.
11. Golino P, Maroko PR, Carew TE, 1987. The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary artery occlusion-reperfusion. Circulation 75: 292-298.
12. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, Downey JM, 1995. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
13. Hartman JC, Kurc GM, Hullinger G, Theron MW, Sheehy RM, Shebuski RJ, 1994. Inhibition of nitric oxide synthase prevents myocardial protection of ramiprilat. J Pharmacol Exp Ther 270: 1071-1076.
14. Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM, 1988. Nitric oxide: A cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 157: 87-94.
15. Jugdutt BI, Hutchins GM, Bulkley BH, Pitt B, Becker LC, 1979. Effect of indomethacin on collateral blood flow and infarct size in the conscious dog. Circulation 64: 734-743.
16. Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC, 1980. Salvage of ischaemic myocardium by ibuprofen during infarction in the conscious dog. Am J Cardiol 46: 74-82.
17. Kostic MM, Schrader J, 1992. Role of nitric oxide in reactive hyperemia of the guinea pig heart. Circ Res 70: 208-212.
18. Lefer AM, Ma X, 1993. Decreased basal nitric oxide release in hypercholesterolamia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscl Thromb 13: 771-776.
19. Lidbury PS, Antunes E, De Nucci G, Vane JR, 1989. Interactions of iloprost and sodium nitroprusside on vascular smooth muscle and platelet aggregation. Br J Pharmacol 98: 1275-1280.
20. Lüscher TF, Tanner FC, Tschudi MR, Noll G, 1993. Endothelial dysfunction in coronary artery disease. Annu Rev Med 44: 395-418.
21. Macdonald PS, Read MA, Dusting GJ, 1988. Synergistic inhibition of platelet aggregation by endothelium derived relaxing factor and prostacyclin. Thromb Res 49: 437-449.
22. Müller B, Maaß B, Sturzebecher S, Witt W, 1987. Effects of iloprost on arrhythmias and infarct size in rats after coronary artery ligation. In Gryglewski RJ, Stock G (eds). Prostacyclin and its Stable Analogue Iloprost. Berlin: Springer-Verlag, 195-204.
23. Pabla R, Buda AJ, Flynn DM, Salzburg DB, Lefer DJ, 1995. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 269: H1113-H1121.
24. Parratt JR, 1994. Protection of the heart by ischaemic preconditioning: Mechanisms and possibilities for the pharmacological exploitation. Trends Pharmacol Sci 15: 19-25.
25. Patel VC, Yellon DM, Singh KJ, Nield GH, Woolfson RG, 1993. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem Biophys Res Commun 194: 234-238.
26. G-nitro-L-arginine. Br J Pharmacol 118: 1433-1440.
27. Pohl U, Lamontagne D, Bassenge E, Busse R, 1994. Attenuation of coronary autoregulation in the isolated rabbit heart by endothelium-derived nitric oxide. Cardiovasc Res 28: 414-419.
28. Radomski MW, Palmer RMJ, Moncada S, 1987. The anti-aggregatory properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 92: 639-646.
29. Richard V, Blanc T, Kaeffer N, Tron C, Thuillez C, 1995. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: Role of nitric oxide. Br J Pharmacol 115: 1532-1538.
30. Schrör K, Woditsch I, Strobach H, Schroder H, 1991. Interactions between nitric oxide and prostacyclin in myocardial ischemia and endothelial cell cultures. Basic Res Cardiol 86 (Suppl. 2): 117-125.
31. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM, 1992. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 260: 668-675.
32. Simpson PJ, Fantone JC, Mickelson JK, Gallagher KP, Lucchesi BR, 1988. Identification of a time window for therapy to reduce experimental canine myocardial injury: Suppression of neutrophil activation during 72 hours of reperfusion. Circ Res 63: 1070-1079.
33. Vane JR, 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232-235.
34. Vane JR, Änggård EE, Botting RM, 1990. Regulatory functions of the vascular endothelium. N Engl J Med 323: 27-37.
35. Weber A, Hohlfeld T, Strobach H, Schrör K, 1993. Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 21: 332-338.
36. Williams MW, Taft CS, Ramnauth S, Zhao Z-Q, Vinton-Johansen J, 1995. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc Res 30: 79-86.
37. Woditsch I, Schrör K, 1992. Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischaemia. Am J Physiol 263: H1390-H1396.
38. Woolfson RG, Patel VC, Neild GY, Yellon DM, 1995. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91: 1545-1551.
39. Yamabe H, Okumura K, Ishizaka H, TSuchiya T, Yasue H, 1992. Role of endothelium-derived nitric oxide in myocardial reactive hyperaemia. Am J Physiol 263: H8-H14.